We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Geron’s Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial

News   Jun 13, 2007

 
Geron’s Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
 
 
 

RELATED ARTICLES

Tropical Flower Could Help Treat Pancreatic Cancer

News

Researchers have created three new molecules similar to Grandifloracin, a chemical found in the tropical plant Uvaria grandiflora, which grows in Malaysia, Indonesia, Thailand and the Philippines.

READ MORE

First-of-a-Kind In Vitro 3D Neural Tissue Model Developed

News

Researchers at the University of Illinois at Urbana-Champaign have successfully used stem cells to engineer living biohybrid nerve tissue to develop 3D models of neural networks with the hopes of gaining a better understanding of how the brain and these networks work.

READ MORE

Criteria for Cancer Clinical Trials Might Be Too Strict

News

Federal regulations may be keeping lung cancer patients out of clinical trials simply because the patients are on medications that might affect the electrical system of the heart. The regulations may be preventing al proportion of patients from participating in clinical trials.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE